The earnings call highlighted significant growth in high-margin businesses like Storz & Bickel and medical cannabis, alongside improved gross margins and progress towards positive adjusted EBITDA. However, these positive developments were offset by declines in the Canadian adult-use segment and challenges in the Australian market, as well as cash flow outflows and delayed growth in Acreage Holdings.

Company Guidance

During the earnings call for Canopy Growth's Q2 fiscal 2025, the company provided guidance indicating a strategic focus on profitability and expansion in key markets. Key metrics highlighted included a net revenue of $63 million, with a notable 32% year-over-year growth in the Storz & Bickel segment driven by strong sales in Germany and the U.S. The company's consolidated gross margin improved to 35%, and adjusted EBITDA loss narrowed to $6 million, representing a 54% improvement from the previous year. Canopy Growth's Canadian medical cannabis business saw a 16% revenue increase, while international markets experienced a 12% growth, with European markets such as Germany and Poland contributing significantly. The guidance also outlined expectations for reduced cash flow deficits moving into the second half of the fiscal year, driven by restored supply lines and strategic investments in product innovation and distribution.

Storz & Bickel Revenue Growth

Storz & Bickel delivered overall net revenue growth of 32% year-over-year, driven by strong demand in Germany and resumption of growth in the U.S.

Medical Cannabis Revenue Increase

Revenue in the Canadian medical cannabis business grew by 16% year-over-year, with strong international growth in Europe, particularly in Poland with 200% increase and Germany with a 47% surge.

Improved Gross Margin

Consolidated gross margin improved by 100 basis points to 35% compared to last year, with consistent performance in the mid-30% range for 4 out of the past 5 quarters.

Positive Adjusted EBITDA Trajectory

Adjusted EBITDA loss improved by 54% compared to last year, with expectations of achieving positive adjusted EBITDA in the coming quarters.

Reduction in Interest Expenses

Interest expenses reduced by USD 14 million annually following a USD 100 million early prepayment of term loan.

---

Canopy Growth Corporation (TSE:WEED) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:WEED Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 15, 2018	2019 (Q1)	- / -0.40	-0.03	-1233.33% (-0.37)	―	―
Nov 14, 2018	2019 (Q2)	- / -0.89	-0.104	-753.85% (-0.78)	―	―
Feb 14, 2019	2019 (Q3)	- / -0.77	0.01	-7750.00% (-0.78)	―	―
Jun 20, 2019	2019 (Q4)	- / -0.98	-0.31	-216.13% (-0.67)	―	―
Aug 14, 2019	2020 (Q1)	- / -3.70	-0.4	-825.00% (-3.30)	―	―
Nov 14, 2019	2020 (Q2)	- / -1.08	-0.888	-21.62% (-0.19)	―	―
Feb 14, 2020	2020 (Q3)	- / -3.50	-7.652	54.26% (+4.15)	―	―
May 29, 2020	2020 (Q4)	- / -37.20	-9.8	-279.59% (-27.40)	―	―
Aug 10, 2020	2021 (Q1)	- / -3.00	-37	91.89% (+34.00)	―	―
Nov 09, 2020	2021 (Q2)	- / -0.90	-10.8	91.67% (+9.90)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

TSE:WEED Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 08, 2024	C$6.30	C$5.90	-6.35%
Aug 09, 2024	C$9.49	C$8.70	-8.32%
May 30, 2024	C$11.59	C$11.78	+1.64%
Feb 09, 2024	C$5.56	C$5.38	-3.24%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---